As of Nov 20
| -0.22 / -0.49%|
The 28 analysts offering 12-month price forecasts for Sanofi have a median target of 51.39, with a high estimate of 58.37 and a low estimate of 43.78. The median estimate represents a +15.95% increase from the last price of 44.32.
The current consensus among 32 polled investment analysts is to Hold stock in Sanofi. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.